MarginsXMarginsX
Home › Markets › GNMSF

Genmab A/S (GNMSF)

GNMSF is quoted over the counter, not listed on an exchange. Genmab A/S files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 12, 2026
$509.50
No trades since Nov 12, 2026; later closes repeat the last quote
1-year return
+67.6%
Market cap
The company also trades on Nasdaq as GMAB; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerGNMSF, quoted over the counter
SEC CIK0001434265
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business address1253 Copenhagen K, Denmark

Warning signs

Cash runway
Cash-flow positive
$1.7B cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed February 17, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-02-17
Cash and burn$1.7B cash; operating cash flow $296.5M a quarter.Report 2025-12-31
Shares outstanding642,384,080 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte Statsautoriseret Revisionspartnerselskab, Copenhagen, DenmarkPCAOB Form AP 2026-03-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$3.7B$963.0M$1.2B$1.7B$5.3B$3.7B20-F 2026-02-17
FY 2024
2024-12-31
$3.1B$1.1B$1.1B$1.4B$0$3.1B20-F 2026-02-17
FY 2023
2023-12-31
$2.4B$631.0M$1.1B$2.2B$0$2.4B20-F 2026-02-17

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42019-07-19
Latest annual report20-F2026-02-17
Latest quarterly / interim6-K2026-11-12

Source: SEC EDGAR submissions feed, 573 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier